Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00042796
Status:
TERMINATED
Last Update Posted:
2013-01-23
First Post:
2002-08-05
Brief Title:
Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Secondary Acute Myeloid Leukemia |
| Childhood Acute Myeloblastic Leukemia With Maturation M2 |
| Childhood Acute Promyelocytic Leukemia M3 |
| Recurrent Childhood Acute Lymphoblastic Leukemia |
| Recurrent Childhood Acute Myeloid Leukemia |
Keywords: